Abstract:The Centers for Disease Control and Prevention has reported that foodborne disease outbreaks associated with fruits and vegetables increased during the past decade. This study was conducted to characterize the routes of microbial contamination in produce and to identify areas of potential contamination from production through postharvest handling. We report here the levels of bacterial indicator organisms and the prevalence of selected pathogens in produce samples collected from the southern United States. A total of 398 produce samples (leafy greens, herbs, and cantaloupe) were collected through production and the packing shed and assayed by enumerative tests for total aerobic bacteria, total coliforms, total Enterococcus, and Escherichia coli. These samples also were analyzed for Salmonella, Listeria monocytogenes, and E. coli O157:H7. Microbiological methods were based on methods recommended by the U.S. Food and Drug Administration. For all leafy greens and herbs, geometric mean indicator levels ranged from 4.5 to 6.2 log CFU/g (aerobic plate count); less than 1 to 4.3 log CFU/g (coliforms and Enterococcus); and less than 1 to 1.5 log CFU/g (E. coli). In many cases, indicator levels remained relatively constant throughout the packing shed, particularly for mustard greens. However, for cilantro and parsley, total coliform levels increased during the packing process. For cantaloupe, microbial levels significantly increased from field through packing, with ranges of 6.4 to 7.0 log CFU/g (aerobic plate count); 2.1 to 4.3 log CFU/g (coliforms); 3.5 to 5.2 log CFU/g (Enterococcus); and less than 1 to 2.5 log CFU/g (E. coli). The prevalence of pathogens for all samples was 0, 0, and 0.7% (3 of 398) for L. monocytogenes, E. coli O157:H7, and Salmonella, respectively. This study demonstrates that each step from production to consumption may affect the microbial load of produce and reinforces government recommendations for ensuring a high-quality product.

Functional Analysis of LIM Domain Proteins and Co-Factors in Breast Cancer

[Involvement of LMO4 in Tumorigenesis Associated Epithelial-Mesenchymal Transition].

The LIM-only Factor LMO4 Regulates Expression of the BMP7 Gene Through an HDAC2-dependent Mechanism, and Controls Cell Proliferation and Apoptosis of Mammary Epithelial Cells.

LMO4 can interact with Smad proteins and modulate transforming growth factor- β signaling in epithelial cells

LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53

LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer

Carcinogenesis promotion in oral squamous cell carcinoma: KDM4A complex-mediated gene transcriptional suppression by LEF1

LIM homeobox transcription factors, a novel subfamily which plays an important role in cancer (review).

Long Noncoding RNA Linc00460 Promotes Breast Cancer Progression by Regulating the Mir-489-5p/fgf7/akt Axis

Squamous Cell Carcinoma And Mammary Abscess Formation Through Squamous Metaplasia In Smad4/Dpc4 Conditional Knockout Mice

Camp Responsive Element Binding Protein-1 is a Transcription Factor of Lysosomal-Associated Protein Transmembrane-4 Beta in Human Breast Cancer Cells.

Bromodomain 4 activation predicts breast cancer survival

Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4

Identification of driver genes and somatic mutations in cell-free DNA of patients with pulmonary lymphangioleiomyomatosis

Coactosin-Like Protein in Breast Carcinoma: Friend or Foe?

Epigenetic identification of LTBP4 as a putative tumor suppressor in breast cancer

A field study of the microbiological quality of fresh produce.

LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 Axis

LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis

Maggot debridement therapy for diabetic necrotic foot.

The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating LAPTM4B Expression